STAA - STAAR Surgical Operating income before deduction of amortization

Public company logo of STAAR Surgical (STAA)

A focus on material biocompatibility and the minimization of defects ensures business stability for STAAR Surgical Company (STAA). The company's aggregate EBITDA on the chart confirms this trend, where 33.02 characterizes this valuation parameter. Dominance in the implant niche is supported by Collamer patents and the complexity of physician training. An expansion strategy in Asia and a focus on youth via a safe alternative to laser vision correction are driving growth.

STAAR Surgical Company (STAA) - Profit before payment of interest, taxes and amortization from 11/23/2025 to 11/13/2026

Summary analytical data breakdowns for STAAR Surgical (STAA)

- stock quotes and analyst forecast:
Price Performance Chart STAAR Surgical Co|STAA - Analyst Consensus Forecast
- market capitalization statistics:
Market Capitalization STAAR Surgical|STAA - Total Company Value
- balance sheet equity data:
Equity per Share STAAR Surgical|STAA - Company Book Value|Market Capitalization to Book Value staar.com|STAA - Cumulative Company Assets
- debt level and financial liquidity data:
Aggregate Debt to Capital STAAR Surgical Company|STAA - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital STAAR Surgical Co.|STAA - Company Total Debt|Debts to Book Capitalization STAAR Surgical|STAA - Company Long-Term Debt|Company Current Liabilities STAAR Surgical|Immediate Liquidity staar.com
- earnings and valuation multiples indicators:
STAA - Company Net Income|Net Profit Forecast STAAR Surgical Company|STAA - Price to Earnings Ratio|Market Cap to Future Earnings Ratio staar.com|STAA - Price/Earnings to Growth Ratio|Total Company Value to Operating Income Before Depreciation Ratio STAAR Surgical|STAA - Profit before payment of interest, taxes and amortization|Net earnings per share for the last four quarters STAAR Surgical|STAA - Net earnings per share for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months staar.com|STAA - Earnings growth in current year|Earnings growth forecast for next year STAAR Surgical Company
- sales and revenue data:
STAA - Revenue and Sales Volume|Projected Sales Volume STAAR Surgical Co|STAA - Price-to-Revenue Ratio|Forward Price to Sales STAAR Surgical
Fundamental company valuation:STAA (STAAR Surgical Co)
Product sample of STAAR Surgical Co.

STAAR Surgical Company (STAA) maintains its monopoly position in the EVO ICL implantable lens segment through the active implementation of innovations in refractive surgery. This indicator measures net cash flow from operating activities, excluding the impact of depreciation and tax liabilities. The metric allows for an assessment of the business's actual ability to act as a cash generator to fund its R&D pipeline. Growth in this indicator confirms the effectiveness of new product commercialization. The price action of the EBITDA reflects the resilience of the operating model.

Competitors of STAAR Surgical Company (STAA)

Income before deduction of interest, taxes and amortization ISRG|Danaher Corp. - Operating profit EBITDA|Operating income before deduction of amortization bd.com BDX|STERIS (STE) - Profit before payment of interest, taxes and amortization|Operating profit before amortization WST|Profit before payment of interest, taxes and amortization Baxter Corp|Masimo Inc. (MASI) - Operating income before deduction of amortization|Operating profit before deduction of amortization STVN (Stevanato Group S.p.A.)|Company profit before taxes, interest and amortization TFX|Profit before payment of interest, taxes and amortization Merit Medical MMSI|Income before deduction of interest, taxes and amortization NVST|ICUI: Operating profit before deduction of amortization|XRAY - Operating profit EBITDA|LeMaitre Vascular, Inc. (LMAT) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization atricure.com|NAGE (ChromaDex Corp.) - Operating profit EBITDA|Profit before interest, taxes and amortization ZimVie Inc ZIMV|Profit before payment of interest, taxes and amortization AngioDynamics Corp (ANGO)|Cerus Inc - Operating profit before amortization|Alpha Teknova, Inc. - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization MGRM (monogramorthopedics.com)|STSS - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization InfuSystem Holdings INFU|Utah Medical (UTMD) - Profit before payment of interest, taxes and amortization|KRMD - Operating income before deduction of amortization|Operating profit before deduction of amortization NYXH|MBOT (microbotmedical.com) - Company profit before taxes, interest and amortization|Operating profit EBITDA PDEX|Operating profit EBITDA Zentek Ltd (ZTEK)|Operating profit EBITDA ELUT (Elutia Corp)|Operating profit EBITDA Milestone Scientific Corporation MLSS|NXGL - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization RVP (Retractable Technologies)|HBIO (Harvard Bioscience) - Operating profit before deduction of amortization|Femasys Inc - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Meihua Medical Technologies|Predictive Oncology Corp (POAI) - Operating income before deduction of amortization|Operating profit before deduction of amortization CJMB (Callan JMB Inc)|Operating profit EBITDA atrioncorp.com (ATRI)|Profit before payment of interest, taxes and amortization NeuroMetrix NURO